The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids

Hyperinflammation is a key component of severe coronavirus disease 2019 (COVID-19) and is associated with poor outcomes. It is imperative to distinguish severe COVID-19 from hyperinflammatory syndromes such as multisystem inflammatory syndrome (MIS) and hemophagocytic lymphohistiocytosis. There is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvaraj, Vijairam, Finn, Arkadiy, Li, Jennifer, Dapaah-Afriyie, Kwame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958274/
https://www.ncbi.nlm.nih.gov/pubmed/35371682
http://dx.doi.org/10.7759/cureus.22614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958274/
https://www.ncbi.nlm.nih.gov/pubmed/35371682
http://dx.doi.org/10.7759/cureus.22614

Ejemplares similares